Muriel Paul

2.4k total citations
87 papers, 1.8k citations indexed

About

Muriel Paul is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Occupational Therapy. According to data from OpenAlex, Muriel Paul has authored 87 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Public Health, Environmental and Occupational Health and 12 papers in Occupational Therapy. Recurrent topics in Muriel Paul's work include Research on Leishmaniasis Studies (13 papers), Protein purification and stability (12 papers) and Safe Handling of Antineoplastic Drugs (12 papers). Muriel Paul is often cited by papers focused on Research on Leishmaniasis Studies (13 papers), Protein purification and stability (12 papers) and Safe Handling of Antineoplastic Drugs (12 papers). Muriel Paul collaborates with scholars based in France, Germany and Italy. Muriel Paul's co-authors include A. Astier, Victoire Vieillard, M Deniau, D. Rivollet, P. Wolkenstein, Hatem Fessi, Rémy Durand, O. Chosidow, Jean‐Claude Roujeau and M.L. Fléchet and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Free Radical Biology and Medicine.

In The Last Decade

Muriel Paul

82 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muriel Paul France 24 404 323 297 282 224 87 1.8k
Radu M. Nanau Canada 21 344 0.9× 144 0.4× 95 0.3× 57 0.2× 98 0.4× 34 1.6k
Raffaele Grande Italy 23 416 1.0× 65 0.2× 94 0.3× 81 0.3× 40 0.2× 64 2.0k
Philippe Bourget France 24 336 0.8× 242 0.7× 101 0.3× 321 1.1× 18 0.1× 91 1.8k
Xiaoting Wang China 27 908 2.2× 56 0.2× 947 3.2× 102 0.4× 86 0.4× 98 2.8k
Roger S. Thrall United States 33 599 1.5× 120 0.4× 718 2.4× 137 0.5× 49 0.2× 96 3.1k
Leon Kircik United States 28 313 0.8× 104 0.3× 1.4k 4.7× 81 0.3× 418 1.9× 356 4.2k
Zhenhua Dai China 30 691 1.7× 145 0.4× 1.9k 6.4× 88 0.3× 118 0.5× 79 3.4k
Mack R. Holdiness United States 19 158 0.4× 158 0.5× 58 0.2× 77 0.3× 53 0.2× 53 1.3k
Lynda R. Wiseman New Zealand 33 675 1.7× 437 1.4× 126 0.4× 122 0.4× 48 0.2× 63 3.1k
Cumhur Gündüz Türkiye 26 788 2.0× 69 0.2× 154 0.5× 342 1.2× 79 0.4× 202 2.2k

Countries citing papers authored by Muriel Paul

Since Specialization
Citations

This map shows the geographic impact of Muriel Paul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muriel Paul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muriel Paul more than expected).

Fields of papers citing papers by Muriel Paul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muriel Paul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muriel Paul. The network helps show where Muriel Paul may publish in the future.

Co-authorship network of co-authors of Muriel Paul

This figure shows the co-authorship network connecting the top 25 collaborators of Muriel Paul. A scholar is included among the top collaborators of Muriel Paul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muriel Paul. Muriel Paul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bellais, Samuel, et al.. (2025). Standardized freeze-dried FMT: is the ideal protectant out there?. Frontiers in Microbiology. 16. 1618067–1618067. 1 indexed citations
2.
Riazi, Afsane, et al.. (2024). Handling and decontamination of live medications: What challenges for hospital pharmacies in France?. Annales Pharmaceutiques Françaises. 83(3). 480–492. 2 indexed citations
3.
Séguin, Johanne, Victoire Vieillard, Philippe Espeau, et al.. (2023). Co-encapsulation of fisetin and cisplatin into liposomes: Stability considerations and in vivo efficacy on lung cancer animal model. International Journal of Pharmaceutics. 651. 123744–123744. 11 indexed citations
4.
Vieillard, Victoire & Muriel Paul. (2023). Physicochemical stability study of a biosimilar of Bevacizumab in vials and after dilution in 0.9% NaCl in polyolefin intravenous bags. SHILAP Revista de lepidopterología. 8(1). 2 indexed citations
5.
Vanden‐Bossche, Arnaud, et al.. (2023). OP0208 MECHANICAL UNLOADING PREVENTED ARTHRITIS IN THE RAT ADJUVANT-INDUCED ARTHRITIS MODEL. Annals of the Rheumatic Diseases. 82. 137–137. 1 indexed citations
6.
Annereau, Maxime, Audrey Solgadi, Victoire Vieillard, et al.. (2023). Identification of Degradation Products of the New Anticancer Drug Substance ONC201 by Liquid Chromatography–High-Resolution Multistage Mass Spectrometry. Chemosensors. 11(5). 294–294. 5 indexed citations
7.
8.
Vieillard, Victoire, et al.. (2020). Physicochemical stability study of MYL-1401O, a biosimilar of trastuzumab, following a transient temperature excursion. Journal of Oncology Pharmacy Practice. 27(4). 847–856. 5 indexed citations
9.
10.
Bazin, Christophe, Victoire Vieillard, A. Astier, & Muriel Paul. (2013). Implementation of real-time identification analysis and quantification of chemotherapies preparations with a Multispec® analyser. Annales Pharmaceutiques Françaises. 72(1). 33–40. 20 indexed citations
11.
Bazin, Christophe, Victoire Vieillard, A. Astier, & Muriel Paul. (2010). Contrôle rapide et fiable des préparations de chimiothérapies à base d’anticorps monoclonaux à l’aide de l’automate Multispec®. Annales Pharmaceutiques Françaises. 68(3). 163–177. 18 indexed citations
12.
Astier, A., et al.. (2009). Development of α-Tocopherol Acetate Nanoparticles: Influence of Preparative Processes. Drug Development and Industrial Pharmacy. 35(2). 216–223. 10 indexed citations
13.
Loiseau, Philippe M., Julia S. Lehman, D. Rivollet, et al.. (2002). Characterisation of atovaquone resistance in Leishmania infantum promastigotes. International Journal for Parasitology. 32(8). 1043–1051. 24 indexed citations
14.
Deniau, M, et al.. (2002). Atovaquone-loaded nanocapsules: influence of the nature of the polymer on their in vitro characteristics. International Journal of Pharmaceutics. 250(1). 273–281. 50 indexed citations
15.
Escudier-Villa, Juan Manuel, et al.. (2000). Désinfection à froid des endoscopes : évaluation despratiques et mesure des actions correctives. Journal de Pharmacie Clinique. 18(4). 306–312. 1 indexed citations
16.
Paul, Muriel, Rémy Durand, Yves Boulard, et al.. (1998). Physicochemical Characteristics of Pentamidine-Loaded Polymethacrylate Nanoparticles: Implication in the Intracellular Drug Release inLeishmania MajorInfected Mice. Journal of drug targeting. 5(6). 481–490. 40 indexed citations
17.
Durand, Rémy, Muriel Paul, D. Rivollet, et al.. (1997). Activity of pentamidine-loaded poly (D, L-lactide) nanoparticles againstLeishmania infantumin a murine model. Parasite. 4(4). 331–336. 23 indexed citations
18.
Fusaı̈, Thierry, Yves Boulard, Rémy Durand, et al.. (1997). Ultrastructural changes in parasites induced by nanoparticle-bound pentamidine in aLeishmania major/mouse model. Parasite. 4(2). 133–139. 19 indexed citations
19.
Durand, Rémy, et al.. (1997). Activity of pentamidine-loaded methacrylate nanoparticles against Leishmania infantum in a mouse model. International Journal for Parasitology. 27(11). 1361–1367. 35 indexed citations
20.
Fusaı̈, Thierry, M Deniau, Rémy Durand, et al.. (1994). Action of pentamidine-bound nanoparticles againstLeishmaniaon anin vivomodel. Parasite. 1(4). 319–324. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Radu M. Nanau Breakdown of academic impact, for papers by Raffaele Grande Breakdown of academic impact, for papers by Philippe Bourget Breakdown of academic impact, for papers by Xiaoting Wang Breakdown of academic impact, for papers by Roger S. Thrall Breakdown of academic impact, for papers by Leon Kircik Breakdown of academic impact, for papers by Zhenhua Dai Breakdown of academic impact, for papers by Mack R. Holdiness Breakdown of academic impact, for papers by Lynda R. Wiseman Breakdown of academic impact, for papers by Cumhur Gündüz
Rankless by CCL
2026